MUN:PUS

Stock Analysis Report

PULSION Medical Systems

Executive Summary

PULSION Medical Systems SE engages in the development and sale of monitoring systems and disposables for diagnosis and treatment of patients worldwide.

Snowflake

Fundamentals

Flawless balance sheet with questionable track record.


Similar Companies

Share Price & News

How has PULSION Medical Systems's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

PUS

4.5%

DE Medical Equipment

1.4%

DE Market


1 Year Return

-3.5%

PUS

15.2%

DE Medical Equipment

3.7%

DE Market

Return vs Industry: PUS underperformed the German Medical Equipment industry which returned 15.2% over the past year.

Return vs Market: PUS underperformed the German Market which returned 3.7% over the past year.


Shareholder returns

PUSIndustryMarket
7 Day0%4.5%1.4%
30 Day4.8%1.4%1.8%
90 Day-1.8%1.1%3.4%
1 Year0.4%-3.5%17.0%15.2%7.0%3.7%
3 Year3.2%-7.6%101.2%96.0%18.5%8.3%
5 Yearn/a275.6%256.7%42.2%22.9%

Price Volatility Vs. Market

How volatile is PULSION Medical Systems's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is PULSION Medical Systems undervalued compared to its fair value and its price relative to the market?

29.41x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Undervalued: Insufficient data to calculate PUS's fair value to establish if it is undervalued.

Significantly Undervalued: Insufficient data to calculate PUS's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: PUS is good value based on its PE Ratio (29.4x) compared to the Medical Equipment industry average (34.1x).

PE vs Market: PUS is poor value based on its PE Ratio (29.4x) compared to the German market (19.3x).


Price to Earnings Growth Ratio

Low PEG Ratio: Insufficient data to calculate PUS's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: PUS is overvalued based on its PB Ratio (8.8x) compared to the DE Medical Equipment industry average (6x).


Next Steps

Future Growth

How is PULSION Medical Systems forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

2.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: PUS's forecast earnings growth (2.4% per year) is above the savings rate (0.2%).

Earnings vs Market: PUS's earnings (2.4% per year) are forecast to grow slower than the German market (12.6% per year).

High Growth Earnings: PUS's earnings are forecast to grow, but not significantly.

Revenue vs Market: Insufficient data to determine if PUS's revenue is forecast to grow faster than the German market.

High Growth Revenue: Insufficient data to determine if PUS's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

High Future ROE: Insufficient data to determine if PUS's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has PULSION Medical Systems performed over the past 5 years?

-1.6%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: PUS's earnings have declined by -1.6% per year over the past 5 years.

Accelerating Growth: PUS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: PUS had negative earnings growth (-8.2%) over the past year, making it difficult to compare to the Medical Equipment industry average (6.4%).


Return on Equity

High ROE: PUS's Return on Equity (29.9%) is considered high.


Return on Assets

ROA vs Industry: PUS has a higher Return on Assets than the Medical Equipment industry average last year.


Return on Capital Employed

ROCE Improving: PUS's Return on Capital Employed has declined over the past 3 years.


Next Steps

Financial Health

How is PULSION Medical Systems's financial position?


Financial Position Analysis

Short Term Liabilities: PUS's short term assets (€15.2M) exceeds its short term liabilities (€9.8M)

Long Term Liabilities: PUS's short term assets (15.2M) exceeds its long term liabilities (4.3M)


Debt to Equity History and Analysis

Debt Level: PUS is debt free.

Reducing Debt: PUS had no debt 5 years ago.

Debt Coverage: PUS has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: PUS has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet

Inventory Level: PUS has a high level of physical assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if PUS's debt is covered by short term assets.


Next Steps

Dividend

What is PULSION Medical Systems's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

company0%marketbottom25%1.5%markettop25%3.8%industryaverage1.4%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate PUS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate PUS's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if PUS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if PUS's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: PUS is not paying a notable dividend for the German market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of PUS's dividend in 3 years as they are not forecast to pay a notable one for the German market.


Next Steps

Management

What is the CEO of PULSION Medical Systems's salary, the management and board of directors tenure and is there insider trading?

0.3yrs

Average board tenure


CEO

PULSION Medical Systems has no CEO, or we have no data on them.


Board Age and Tenure

0.3yrs

Average Tenure

Experienced Board: PUS's board of directors are not considered experienced ( 0.3 years average tenure), which suggests a new board.


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown


Management Team

  • Sergej Kammerzell

    Managing Director

    • Tenure: 0yrs
  • Stephan Haft

    MD of Finance & Investor Relations and Director

    • Tenure: 0.3yrs
  • Petra Heesen

    Head of Human Resources

    • Tenure: 0yrs

Board Members

  • Stephan Haft

    MD of Finance & Investor Relations and Director

    • Tenure: 0.3yrs
  • Jens Viebke (52yo)

    Chairman of the Board

    • Tenure: 0yrs
  • Michael Vallon

    Vice- Chairman of the Board

    • Tenure: 0yrs
  • Elin Frostehav

    Director

    • Tenure: 0.3yrs
  • Niclas Sjöswärd

    Director

    • Tenure: 0.3yrs

Company Information

PULSION Medical Systems SE's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: PULSION Medical Systems SE
  • Ticker: PUS
  • Exchange: MUN
  • Founded: 1990
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: €181.388m
  • Shares outstanding: 8.24m
  • Website: https://www.pulsion.com

Number of Employees


Location

  • PULSION Medical Systems SE
  • Hans-Riedl-Strasse 21
  • Feldkirchen
  • Bavaria
  • 85622
  • Germany

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
0NFXLSE (London Stock Exchange)YesBearer SharesGBEURJun 2001
PUSMUN (Boerse Muenchen)YesBearer SharesDEEURJun 2001

Biography

PULSION Medical Systems SE engages in the development and sale of monitoring systems and disposables for diagnosis and treatment of patients worldwide. The company offers its principal products in the fiel ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/18 21:20
End of Day Share Price2019/10/18 00:00
Earnings2018/12/31
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.